Life Science Company News

Results 401 - 420 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20 21  22  23  24  25 »

Medicenna Therapeutics Announces Closing of CA$20 Million Investment from RA Capital Management

Read more ››
By: GlobeNewswire - 30 Apr 2024

Biodexa’s Licensor Emtora to Announce Phase 2 Clinical Trial Results of eRapa™ in Familial Adenomatous Polyposis to be Presented at Prestigious 2024 Digestive Disease Week Annual Meeting

Read more ››
By: GlobeNewswire - 30 Apr 2024

Press Release: Annual General Meeting of April 30, 2024

Read more ››
By: GlobeNewswire - 30 Apr 2024

Resolutions from the annual shareholders’ meeting 2024

Read more ››
By: GlobeNewswire - 30 Apr 2024

EssilorLuxottica: EssilorLuxottica 2024 Annual Shareholders’ Meeting, starting a new chapter of the Company’s history

Read more ››
By: GlobeNewswire - 30 Apr 2024

AB Science announces a slight delay in the publication of its 2023 annual financial report

Read more ››
By: GlobeNewswire - 30 Apr 2024

Synaptive Medical Showcases First Clinical Use of Near-Infrared Fluorescence Visualization on Robotic Exoscope at the American Association of Neurological Surgeons Annual Meeting

Read more ››
By: GlobeNewswire - 30 Apr 2024

XORTX Reprices Warrants Issued in Connection with Previous Private Placements

Read more ››
By: GlobeNewswire - 30 Apr 2024

BioSig Technologies, Inc. Appoints Mr. Anthony Amato to Position of Chief Executive Officer, Effective Immediately

Read more ››
By: GlobeNewswire - 30 Apr 2024

A Potential First-In-Class Drug: CDE Approved Single-Arm Pivotal Clinical Study of LBL-024, An Anti-PD-L1/4-1BB Bispecific Antibody Developed by Leads Biolabs

Read more ››
By: PR Newswire Association LLC. - 30 Apr 2024

Journal of Pharmaceutical Analysis Articles Reveal the Importance of Phytocompounds and Metabolomics Analysis

Read more ››
By: PR Newswire Association LLC. - 30 Apr 2024

Ingenium Therapeutics Novel NK Cell Therapy Receives Orphan Drug Designation From FDA

Read more ››
By: PR Newswire Association LLC. - 30 Apr 2024

National Medical Products Administration (NMPA) Approves Chipscreen Bioscience's Chidamide (Epidaza) combined with R-CHOP for the treatment of diffuse large B-cell lymphoma

Read more ››
By: PR Newswire Association LLC. - 30 Apr 2024

WindRose Health Investors Completes Majority Growth Investment in SubjectWell

Read more ››
By: PR Newswire Association LLC. - 30 Apr 2024

DolCas Biotech demonstrates Curcugen® in chocolate at Vitafoods

Read more ››
By: PR Newswire Association LLC. - 30 Apr 2024

Harmony Biosciences Acquires Epygenix Therapeutics, Inc., Adding Late-Stage Epilepsy Franchise to Growing Pipeline of Innovative CNS Assets

Read more ››
By: PR Newswire Association LLC. - 30 Apr 2024

ELIAS Animal Health Expands Manufacturing Capacity Ahead of Product Approval and Pipeline Expansion

Read more ››
By: PR Newswire Association LLC. - 30 Apr 2024

HanAll Biopharma Reports Q1 2024 Financial Results and Provides Business Update

Read more ››
By: PR Newswire Association LLC. - 30 Apr 2024

I-MAB Filed 2023 Annual Report on Form 20-F

Read more ››
By: PR Newswire Association LLC. - 30 Apr 2024

BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS

Read more ››
By: PR Newswire Association LLC. - 30 Apr 2024
Results 401 - 420 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20 21  22  23  24  25 »

Enhance your business development with Biotechgate